Posted by Michael Wonder on 29 Oct 2023
100,000 patients eligible for heart drug under PBS
28 October 2023 - Almost 100,000 patients are set to save hundreds of dollars per year as access to a chronic heart failure treatment is widened under the PBS.
From November 1, criteria to access empagliflozin, known by the brand name Jardiance, will be expanded.
